In adult patients requiring volume resuscitation, when should balanced crystalloids be used instead of colloids, and what are the indications for colloid use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Crystalloids vs Colloids for Volume Resuscitation

Use balanced crystalloids as your first-line fluid for volume resuscitation in all critically ill patients, including sepsis, septic shock, trauma, and hemorrhagic shock. 1, 2

Initial Resuscitation Strategy

Start with crystalloids as the fluid of choice for initial resuscitation and subsequent intravascular volume replacement 1. The Surviving Sepsis Campaign 2016 guidelines provide a strong recommendation (Grade 1B) for crystalloids over colloids, with specific contraindication against hydroxyethyl starches 1.

Crystalloid Selection: Balanced vs Normal Saline

Prefer balanced crystalloids (Ringer's Lactate or Plasmalyte) over 0.9% normal saline to reduce mortality and adverse renal events 2. While the recommendation strength is weaker (Grade 2+), the 2022 French guidelines specifically favor balanced solutions in:

  • Sepsis and septic shock patients
  • Hemorrhagic shock resuscitation
  • Any situation requiring large volume resuscitation

The rationale is compelling: normal saline in high volumes causes hyperchloremic acidosis, which has been associated with impaired renal function and increased mortality in observational studies 2.

When to Consider Albumin

Add albumin to crystalloids only when patients require substantial amounts of crystalloids 1, 2. This is a weak recommendation (Grade 2C) but represents the only colloid with reasonable safety data.

Specific considerations for albumin:

  • Use as second-line therapy after crystalloids prove insufficient
  • The ALBIOS study showed improved cardiovascular SOFA scores and reduced vasopressor duration, though no mortality benefit 2
  • More effective at maintaining plasma volume expansion than synthetic colloids when capillary permeability is increased 3
  • Safer renal profile compared to synthetic colloids

Do not use albumin as first-line therapy - there is insufficient evidence to justify routine use, and it is significantly more expensive than crystalloids 2.

Colloids to Avoid

Hydroxyethyl Starches (HES)

Never use hydroxyethyl starches - this is a strong recommendation with high-quality evidence (Grade 1B) 1. HES solutions:

  • Significantly increase risk of renal failure (OR 1.30,95% CI 1.14-1.48) 4
  • Increase need for renal replacement therapy 1, 5
  • Cause hemostasis disorders and increase bleeding risk 2
  • Increase transfusion requirements 2
  • Associated with higher 90-day mortality compared to crystalloids 5

Gelatins

Use crystalloids over gelatins (weak recommendation) 1. Gelatins show limited effectiveness and offer no clear advantage over crystalloids 2, 6.

Dextrans

Avoid dextrans due to:

  • Risk of anaphylaxis 6
  • Potential increased risk of renal failure 6
  • No mortality benefit over crystalloids 5

Practical Algorithm

  1. Start with balanced crystalloids (Ringer's Lactate or Plasmalyte)

    • Initial bolus: minimum 30 mL/kg for sepsis-induced hypoperfusion 1
    • Continue fluid challenges while hemodynamic parameters improve
  2. Monitor for adequate response:

    • Mean arterial pressure ≥65 mmHg
    • Improved tissue perfusion markers
    • Urine output restoration
  3. If requiring massive crystalloid volumes (typically >5-10 liters):

    • Consider adding 4-5% albumin 2
    • Continue monitoring renal function and fluid balance
  4. Never use:

    • Hydroxyethyl starches (any generation)
    • Gelatins (unless no alternative available)
    • Dextrans

Critical Pitfalls to Avoid

  • Don't delay crystalloid administration waiting to obtain colloids - time to adequate resuscitation matters more than fluid type 6
  • Don't use normal saline exclusively in high-volume resuscitation - switch to balanced crystalloids to prevent hyperchloremic acidosis 2
  • Don't assume colloids are more efficient - in critically ill patients with increased capillary permeability, similar volumes of crystalloids and colloids are required, negating the theoretical advantage of colloids 4, 3
  • Don't use synthetic colloids to "save kidneys" - they actually increase renal injury risk 1, 2, 5

Evidence Quality Note

The evidence strongly favors crystalloids with high-certainty data showing no mortality benefit for any colloid over crystalloids, while synthetic colloids demonstrate clear harm 5. The 2022 guidelines 2 represent the most current expert consensus, reinforcing and updating the 2016 Surviving Sepsis Campaign recommendations 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.